Zhejiang Jolly Pharmaceutical Co.,LTD Financials

Market Capitalization CN¥13.31 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	24.03
Forward PE	19.77
Price to Sales TTM	CN¥4.88
Price to Book MRQ	CN¥4.21
Enterprise to Revenue	4.34
Enterprise to EBITDA	16.97

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	20.02%
Operating Margin	26.05%
Return on Assets TTM	9.34%
Return on Equity TTM	18.23%

Income Statement

Revenue TTM	CN¥2,729,404,416
Revenue per Share TTM	CN¥3.92
Quarterly Revenue Growth	22.50%
Gross Profit TTM	CN¥1,612,455,552
EBITDA	CN¥674,614,316
Net Income to Common TTM	CN¥546,508,032
Diluted EPS TTM	CN¥0.79
Quarterly Earnings Growth YoY	27.20%

Balance Sheet

Total Cash MRQ	CN¥741,031,296
Total Cash per Share MRQ	CN¥1.07
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	16.77
Current Ratio MRQ	2.01
Book Value per Share MRQ	CN¥4.51

Cash Flow

Operating Cash Flow TTM	CN¥202,541,408
Levered Free Cash Flow TTM	CN¥-275,078,304

300181 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	701,387,335
Float Shares	506,519,027
Avg 10 Volume	18,242,034
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	26.61%
% Held by Institutions	15.91%

Stock Price Summary

Beta	0.20
Fifty Two Week Low	CN¥11.53
Fifty Two Week High	CN¥19.15
Fifty Two Week Change	21.50%
Day 50 MA	CN¥16.66
Day 200 MA	CN¥15.88

Dividends and Splits

Forward Annual Dividend Rate	CN¥2.40
Forward Annual Dividend Yield	12.64%
Trailing Annual Dividend Rate	CN¥0.60
Trailing Annual Dividend Yield	3.16%
Payout Ratio	57.30%
Dividend Date
Ex Dividend Date	2025-05-26
Last Split Factor
Last Split Date	2015-05-20